Mabpharm Limited (HKG:2181)

Hong Kong · Delayed Price · Currency is HKD

0.4350

+0.0050 (1.16%)

Aug 27, 2026, 1:42 PM HKT

Mabpharm Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	109.26	89.34	173.35	33.57	81.56
Trading Asset Securities	-	-	-	15.04	-
Cash & Short-Term Investments	109.26	89.34	173.35	48.61	81.56
Cash Growth	22.29%	-48.46%	256.59%	-40.39%	-83.18%
Accounts Receivable	155.06	94.53	19.42	9.53	0.79
Other Receivables	3.48	9.2	23.97	30.66	41.47
Receivables	158.54	103.73	43.39	40.2	42.27
Inventory	136.56	111.01	102.04	100.8	53.21
Restricted Cash	-	39.34	-	-	-
Other Current Assets	29.94	22.35	23.43	11.52	70.74
Total Current Assets	434.3	365.77	342.21	201.12	247.77
Property, Plant & Equipment	568.99	614.25	686.54	704.01	561.05
Long-Term Deferred Tax Assets	52.97	-	-	-	-
Long-Term Deferred Charges	96.26	33.35	-	-	-
Other Long-Term Assets	0.94	2.85	6.23	12.39	91.09
Total Assets	1,153	1,016	1,035	917.52	899.9

Liabilities

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	30.17	11.71	10.03	16.77	60.09
Accrued Expenses	53.75	36.1	47.25	54.73	57.9
Short-Term Debt	-	-	-	-	0.74
Current Portion of Long-Term Debt	210.13	80.05	108.26	-	-
Current Portion of Leases	23.6	17.21	17	13.29	9.28
Current Income Taxes Payable	11.32	0.63	0.66	0.94	1.2
Current Unearned Revenue	56.39	45.5	40.28	26.6	37.93
Other Current Liabilities	148.69	120.93	92.72	76.07	67.87
Total Current Liabilities	534.04	312.13	316.19	188.4	235
Long-Term Debt	66.29	184.04	123.97	129.71	-
Long-Term Leases	26.72	30.29	33.35	28.34	36.41
Long-Term Unearned Revenue	321.82	351.95	308.03	122.43	26.51
Other Long-Term Liabilities	47.28	48.88	48.38	47.7	-
Total Liabilities	996.16	927.28	829.92	516.58	297.92

Shareholders' Equity

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	2.8	2.8	2.8	2.8	2.8
Additional Paid-In Capital	1,401	1,401	1,401	1,401	1,401
Retained Earnings	-1,303	-1,361	-1,233	-1,023	-812.5
Comprehensive Income & Other	57.48	46.25	34.42	20.95	11.17
Total Common Equity	157.3	88.93	205.06	400.94	601.98
Shareholders' Equity	157.3	88.93	205.06	400.94	601.98
Total Liabilities & Equity	1,153	1,016	1,035	917.52	899.9

Additional Metrics

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	326.74	311.59	282.57	171.34	46.43
Net Cash (Debt)	-217.48	-222.25	-109.23	-122.73	35.13
Net Cash Growth	-	-	-	-	-92.10%
Net Cash Per Share	-0.05	-0.05	-0.03	-0.03	0.01
Filing Date Shares Outstanding	4,124	4,124	4,124	4,124	4,124
Total Common Shares Outstanding	4,124	4,124	4,124	4,124	4,124
Working Capital	-99.74	53.65	26.02	12.72	12.77
Book Value Per Share	0.04	0.02	0.05	0.10	0.15
Tangible Book Value	157.3	88.93	205.06	400.94	601.98
Tangible Book Value Per Share	0.04	0.02	0.05	0.10	0.15
Buildings	198.29	198.29	198.21	117.92	117.92
Machinery	396.66	389.32	357.53	335.14	280.95
Construction In Progress	128.66	125.3	167.23	239.12	98.4
Leasehold Improvements	82.14	79.09	78.79	78.79	78.63